Invention Grant
- Patent Title: RSV immunization regimen
-
Application No.: US13982206Application Date: 2012-01-26
-
Publication No.: US10342862B2Publication Date: 2019-07-09
- Inventor: Phillip Dormitzer
- Applicant: Phillip Dormitzer
- Applicant Address: BE Rixensart
- Assignee: GlaxoSmithKline Biologicals, SA
- Current Assignee: GlaxoSmithKline Biologicals, SA
- Current Assignee Address: BE Rixensart
- Agent Eric J. Kron
- International Application: PCT/US2012/022762 WO 20120126
- International Announcement: WO2012/103361 WO 20120802
- Main IPC: A61K39/155
- IPC: A61K39/155 ; C12N15/86 ; A61K39/12 ; A61K39/00
Abstract:
The invention relates to an immunization regimen whereby an infant is protected against respiratory syncytial virus (RSV) through administration of a first anti-RSV immune response inducing composition to his or her mother during pregnancy, followed by administration of a second anti-RSV immune response inducing composition to the infant after birth.
Public/Granted literature
- US20140044751A1 RSV IMMUNIZATION REGIMEN Public/Granted day:2014-02-13
Information query
